Cytotoxicity and antitumor activity of the phosphate prodrug of a novel microtubule inhibitor.

被引:0
|
作者
Houze, J [1 ]
Gergely, J [1 ]
Schwendner, S [1 ]
Hoffman, L [1 ]
Beckmann, H [1 ]
Baichwal, V [1 ]
Roche, D [1 ]
Jaen, J [1 ]
机构
[1] Tularik Inc, S San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
635
引用
收藏
页码:3857S / 3857S
页数:1
相关论文
共 50 条
  • [31] Antitumor activity of a novel and orally available inhibitor of serine palmitoyltransferase
    Yaguchi, Masahiro
    Shibata, Sachio
    Satomi, Yoshinori
    Hirayama, Megumi
    Adachi, Ryutaro
    Asano, Yasutomi
    Kojima, Takuto
    Hirata, Yasuhiro
    Mizutani, Akio
    Kiba, Atsushi
    Sagiya, Yoji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 484 (03) : 493 - 500
  • [32] ANTITUMOR ACTIVITY OF SULFATED ANGIOGENIC FRAGMENTS: A NOVEL HYALURONIDASE INHIBITOR
    Hennig, Martin J. P.
    Lokeshwar, Soum D.
    Wilson, Shenelle N.
    Jordan, Andre R.
    Chipollini, Juan
    Hupe, Marie C.
    Kramer, Mario W.
    Lopez, Luis E.
    Merseburger, Axel S.
    Lokeshwar, Vinata B.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E803 - E803
  • [33] Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor
    Dorr, RT
    Dvorakova, K
    Snead, K
    Alberts, DS
    Salmon, SE
    Pettit, GR
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (02) : 131 - 137
  • [34] In vitro cross species metabolism of a novel RAF kinase inhibitor phosphate prodrug, ARQ 736
    Hall, Terence
    Bresciano, Karen
    Volak, Laurie
    Wang, Yunxia
    Zhong, Caiyun
    Liu, Yanbin
    Lapierre, Jean-Marc
    Savage, Ronald E.
    Chan, Thomas C. K.
    CANCER RESEARCH, 2011, 71
  • [35] Combretoxazolones: Synthesis, cytotoxicity and antitumor activity
    Nam, NH
    Kim, Y
    You, YJ
    Hong, DH
    Kim, HM
    Ahn, BZ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (23) : 3073 - 3076
  • [36] TTI-237:: A novel microtubule-active compound with in vivo antitumor activity
    Beyer, Carl F.
    Zhang, Nan
    Hernandez, Richard
    Vitale, Danielle
    Lucas, Judy
    Nguyen, Thai
    Discafani, Carolyn
    Ayral-Kaloustian, Semiramis
    Gibbons, James J.
    CANCER RESEARCH, 2008, 68 (07) : 2292 - 2300
  • [37] Analogues of cylindrol A, a novel farnesyl protein transferase inhibitor.
    Cermak, SC
    Wilson, JM
    Wiemer, DF
    Hohl, RJ
    LewisTibesar, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 55 - MEDI
  • [38] Antitumor activity of a kinesin inhibitor
    Sakowicz, R
    Finer, JT
    Beraud, C
    Crompton, A
    Lewis, E
    Fritsch, A
    Lee, Y
    Mak, J
    Moody, R
    Turincio, R
    Chabala, JC
    Gonzales, P
    Roth, S
    Weitman, S
    Wood, KW
    CANCER RESEARCH, 2004, 64 (09) : 3276 - 3280
  • [39] Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome
    Demo, Susan D.
    Kirk, Christopher J.
    Aujay, Monette A.
    Buchholz, Tonia J.
    Dajee, Maya
    Ho, Mark N.
    Jiang, Jing
    Laidig, Guy J.
    Lewis, Evan R.
    Parlati, Francesco
    Shenk, Kevin D.
    Smyth, Mark S.
    Sun, Congcong M.
    Vallone, Marcy K.
    Woo, Tina M.
    Molineaux, Christopher J.
    Bennett, Mark K.
    CANCER RESEARCH, 2007, 67 (13) : 6383 - 6391
  • [40] IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma
    Martel-Frachet, Veronique
    Keramidas, Michelle
    Nurisso, Alessandra
    DeBonis, Salvatore
    Rome, Claire
    Coll, Jean-Luc
    Boumendjel, Ahcene
    Skoufias, Dimitrios A.
    Ronot, Xavier
    ONCOTARGET, 2015, 6 (16) : 14669 - 14686